018457573

STILLWATER

---

April 20, 2021

Trademark Summary

The trademark application STILLWATER was filed by Neurocrine Biosciences, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 7, 2021, and it was registered by office on October 14, 2021 without any oppositions.

The application was filed in English (Italian was selected as the second language).

---

Goods And Services

• The mark was filed in class 42 with following description of goods:
  
  1. Pharmaceutical research and development services
  2. Conducting clinical trials for pharmaceutical preparations
  3. Conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results
  4. Pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders
  5. Conducting clinical trials for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders
  6. Conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders
  7. Providing research information to patients and practitioners as to the results of clinical trials
  8. Providing research information to patients and practitioners as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders.
• The mark was filed in class 44 with Providing medical information and providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders..